We are live on
!
Find out more
MLICM
Metropolitan Life Insurance Company (MetLife) Portfolio holdings
AUM
$328M
1-Year Est. Return
9.77%
This Fund
S&P 500
This Quarter
Est. Return
+4.37%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$7.53B
AUM Growth
-$8.45B
(-53%)
Cap. Flow
-$9.27B
Cap. Flow
% of AUM
-123.16%
Top 10 Holdings %
Top 10 Hldgs %
33.43%
Holding
2,587
New
127
Increased
54
Reduced
2,293
Closed
88
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$11.4M |
| 2 |
American Electric Power
AEP
|
+$5.7M |
| 3 |
BPMP
BP Midstream Partners LP Common Units representing Limited Partner Interests
BPMP
|
+$4.35M |
| 4 |
Clorox
CLX
|
+$3.38M |
| 5 |
KLA
KLAC
|
+$3.27M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$277M |
| 2 |
Bank of America
BAC
|
+$216M |
| 3 |
Microsoft
MSFT
|
+$202M |
| 4 |
Amazon
AMZN
|
+$140M |
| 5 |
Meta Platforms (Facebook)
META
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 29.11% |
| 2 | Technology | 11.55% |
| 3 | Healthcare | 8.57% |
| 4 | Industrials | 7.86% |
| 5 | Consumer Discretionary | 6.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Amdocs
DOX
$6.23B
| $272K | ﹤0.01% |
4,151
-209
| -5% | -$13.6K |
|
1702
St. Joe Company
JOE
$3.89B
| $272K | ﹤0.01% |
15,073
-20,729
| -58% | -$384K |
|
1703
Southern Copper
SCCO
$158B
| $272K | ﹤0.01% |
6,249
-66
| -1% | -$2.62K |
|
|
INFN
1704
DELISTED
Infinera Corporation Common Stock
INFN
| $272K | ﹤0.01% |
42,914
-53,708
| -56% | -$409K |
|
|
JCP
1705
DELISTED
J.C. Penney Company, Inc.
JCP
| $272K | ﹤0.01% |
+85,942
| New | +$277K |
|
1706
Quanex
NX
$981M
| $271K | ﹤0.01% |
11,589
-13,375
| -54% | -$296K |
|
|
CSII
1707
DELISTED
Cardiovascular Systems, Inc.
CSII
| $271K | ﹤0.01% |
11,422
-10,756
| -48% | -$271K |
|
|
LBAI
1708
DELISTED
Lakeland Bancorp Inc
LBAI
| $270K | ﹤0.01% |
14,051
-15,061
| -52% | -$305K |
|
|
CIR
1709
DELISTED
CIRCOR International, Inc
CIR
| $270K | ﹤0.01% |
5,544
-5,239
| -49% | -$256K |
|
|
AHRT
1710
AH Realty Trust
AHRT
$506M
| $269K | ﹤0.01% |
17,303
-13,475
| -44% | -$200K |
|
1711
Andersons Inc
ANDE
$2.21B
| $269K | ﹤0.01% |
8,638
-10,331
| -54% | -$344K |
|
|
DENN
1712
DELISTED
Denny's
DENN
| $269K | ﹤0.01% |
20,330
-23,973
| -54% | -$312K |
|
1713
Ecovyst
ECVT
$1.1B
| $269K | ﹤0.01% |
+16,355
| New | +$268K |
|
|
PGRE
1714
DELISTED
Paramount Group
PGRE
| $269K | ﹤0.01% |
16,957
+29
| +0.2% | +$465 |
|
1715
SFL Corp
SFL
$1.61B
| $269K | ﹤0.01% |
17,356
-24,354
| -58% | -$366K |
|
|
RVNC
1716
DELISTED
Revance Therapeutics, Inc.
RVNC
| $269K | ﹤0.01% |
7,537
-8,085
| -52% | -$232K |
|
1717
Zillow
Z
$8.08B
| $268K | ﹤0.01% |
6,546
+86
| +1% | +$3.54K |
|
|
CCF
1718
DELISTED
Chase Corporation
CCF
| $268K | ﹤0.01% |
2,224
-2,897
| -57% | -$344K |
|
|
FBC
1719
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $268K | ﹤0.01% |
7,165
-6,482
| -47% | -$238K |
|
1720
iShares Russell 1000 ETF
IWB
$50.5B
| $267K | ﹤0.01% |
1,800
-2,900
| -62% | -$420K |
|
|
HT
1721
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $267K | ﹤0.01% |
15,363
-16,581
| -52% | -$297K |
|
1722
SPS Commerce
SPSC
$2.86B
| $266K | ﹤0.01% |
10,948
-10,918
| -50% | -$280K |
|
1723
1st Source
SRCE
$2.13B
| $266K | ﹤0.01% |
5,383
-5,641
| -51% | -$286K |
|
1724
Virtus Investment Partners
VRTS
$1.14B
| $266K | ﹤0.01% |
2,313
-2,384
| -51% | -$280K |
|
|
LMNX
1725
DELISTED
Luminex Corp
LMNX
| $266K | ﹤0.01% |
13,510
-14,073
| -51% | -$293K |
|
Similar funds
GWM
KSCM
AFS
BAM
ML
BCM
ECH
PCM
Metropolitan Life Insurance Company (MetLife)'s Q4 2017 Portfolio in Review
As of Q4 2017, Metropolitan Life Insurance Company (MetLife) held 2,587 positions worth $7.53B, down 53% from $16B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Metropolitan Life Insurance Company (MetLife) withdrew a net $9.27B in Q4 2017, closing 88 positions and reducing 2,293 holdings. Its most notable exit was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $89.8M position sold in full.
By sector, the portfolio is most concentrated in Financials at 29% of assets, up from 23% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Metropolitan Life Insurance Company (MetLife) opened a new position in CVS Health worth $11.4M.
- Metropolitan Life Insurance Company (MetLife)'s largest Q4 2017 buy was CVS Health: 157,105 shares worth $11.4M.
- Metropolitan Life Insurance Company (MetLife) added most to iShares National Muni Bond ETF in Q4 2017, an estimated $3M increase.
- Metropolitan Life Insurance Company (MetLife)'s biggest Q4 2017 reduction was Apple, cutting an estimated $277M.
- Metropolitan Life Insurance Company (MetLife) fully exited iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2017, selling an estimated $89.8M.
- Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 33% of its $7.53B portfolio in Q4 2017.
- Metropolitan Life Insurance Company (MetLife) opened 127 new positions and closed 88 in Q4 2017.
- Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 53% quarter-over-quarter to $7.53B.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2017, filed 15 Feb 2018.